This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: The Brigham and Women's Hospital, Inc., Battelle Memorial Institute. Active years: 2005-2007.
Company Filing History:


Years Active: 2005-2007
Title: The Innovations of Samuel C Mok
Introduction
Samuel C Mok is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to ovarian cancer. With a total of 4 patents, Mok's work has the potential to impact women's health positively.
Latest Patents
Mok's latest patents include groundbreaking inventions aimed at improving the detection of ovarian cancer. One of his notable patents is titled "Eosinophil-derived neurotoxin as a marker for ovarian cancer." This invention focuses on methods for identifying women at increased risk of ovarian cancer by analyzing biological samples for elevated levels of eosinophil-derived neurotoxin (EDN). Another significant patent is "Methods of detecting cancer based on osteopontin," which involves diagnostic methods based on the expression of the protein prostasin. This patent is particularly concerned with assays performed on women to assess their risk of ovarian cancer.
Career Highlights
Throughout his career, Mok has worked with prestigious institutions, including Brigham and Women's Hospital, Inc. and Battelle Memorial Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to innovative research.
Collaborations
Mok has collaborated with notable colleagues such as Kwong-Kwok Wong and Bin Ye. These partnerships have further enhanced his research and development efforts in medical diagnostics.
Conclusion
Samuel C Mok's contributions to the field of ovarian cancer detection through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for improved diagnostic methods that can significantly benefit women's health.